ALKERMES PLC (ALKS) Stock Fundamental Analysis
USA - NASDAQ:ALKS - IE00B56GVS15 - Common Stock
31.59 USD
-0.09 (-0.28%)
ALKS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. ALKS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ALKS is not valued too expensively and it also shows a decent growth rate. These ratings would make ALKS suitable for quality investing!
1. Profitability
1.1 Basic Checks
ALKS had positive earnings in the past year.
In the past year ALKS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALKS reported negative net income in multiple years.
ALKS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 14.54%, ALKS belongs to the top of the industry, outperforming 95.51% of the companies in the same industry.
ALKS has a better Return On Equity (19.55%) than 95.69% of its industry peers.
ALKS has a better Return On Invested Capital (16.21%) than 96.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.54% | ||
| ROE | 19.55% | ||
| ROIC | 16.21% |
ROA(3y)8.82%
ROA(5y)3.68%
ROE(3y)13.16%
ROE(5y)4.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 22.27%, ALKS belongs to the top of the industry, outperforming 95.13% of the companies in the same industry.
ALKS's Operating Margin of 23.57% is amongst the best of the industry. ALKS outperforms 95.51% of its industry peers.
ALKS has a Gross Margin of 85.93%. This is amongst the best in the industry. ALKS outperforms 88.20% of its industry peers.
ALKS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.57% | ||
| PM (TTM) | 22.27% | ||
| GM | 85.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.43%
GM growth 5Y-0.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ALKS is creating value.
ALKS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALKS has more shares outstanding
There is no outstanding debt for ALKS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
ALKS has an Altman-Z score of 6.61. This indicates that ALKS is financially healthy and has little risk of bankruptcy at the moment.
ALKS has a Altman-Z score of 6.61. This is in the better half of the industry: ALKS outperforms 77.53% of its industry peers.
ALKS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.61 |
ROIC/WACC2.09
WACC7.74%
2.3 Liquidity
ALKS has a Current Ratio of 3.67. This indicates that ALKS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.67, ALKS is in line with its industry, outperforming 43.07% of the companies in the same industry.
ALKS has a Quick Ratio of 3.27. This indicates that ALKS is financially healthy and has no problem in meeting its short term obligations.
ALKS has a Quick ratio (3.27) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.67 | ||
| Quick Ratio | 3.27 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 19.71% over the past year.
ALKS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.50% yearly.
ALKS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.08%.
ALKS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.87% yearly.
EPS 1Y (TTM)19.71%
EPS 3Y54.92%
EPS 5Y32.5%
EPS Q2Q%-31.94%
Revenue 1Y (TTM)1.08%
Revenue growth 3Y9.89%
Revenue growth 5Y5.87%
Sales Q2Q%4.24%
3.2 Future
ALKS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.73% yearly.
The Revenue is expected to grow by 8.56% on average over the next years. This is quite good.
EPS Next Y-48.02%
EPS Next 2Y-31.39%
EPS Next 3Y-19.38%
EPS Next 5Y-4.73%
Revenue Next Year-2.6%
Revenue Next 2Y10.16%
Revenue Next 3Y6.82%
Revenue Next 5Y8.56%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.74, which indicates a correct valuation of ALKS.
Compared to the rest of the industry, the Price/Earnings ratio of ALKS indicates a rather cheap valuation: ALKS is cheaper than 97.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALKS to the average of the S&P500 Index (25.67), we can say ALKS is valued rather cheaply.
With a Price/Forward Earnings ratio of 23.14, ALKS is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ALKS is valued cheaper than 91.95% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALKS to the average of the S&P500 Index (31.86), we can say ALKS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.74 | ||
| Fwd PE | 23.14 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ALKS is valued cheaply inside the industry as 97.19% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ALKS is valued cheaply inside the industry as 97.94% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.62 | ||
| EV/EBITDA | 9.33 |
4.3 Compensation for Growth
The decent profitability rating of ALKS may justify a higher PE ratio.
ALKS's earnings are expected to decrease with -19.38% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.39
EPS Next 2Y-31.39%
EPS Next 3Y-19.38%
5. Dividend
5.1 Amount
No dividends for ALKS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ALKS (11/7/2025, 10:49:08 AM)
31.59
-0.09 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners104.46%
Inst Owner Change0.1%
Ins Owners1.66%
Ins Owner Change1.36%
Market Cap5.21B
Revenue(TTM)1.52B
Net Income(TTM)338.83M
Analysts80.91
Price Target44.61 (41.22%)
Short Float %8.93%
Short Ratio7.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)66.1%
Min EPS beat(2)59.84%
Max EPS beat(2)72.36%
EPS beat(4)4
Avg EPS beat(4)43.68%
Min EPS beat(4)12.02%
Max EPS beat(4)72.36%
EPS beat(8)4
Avg EPS beat(8)10.27%
EPS beat(12)8
Avg EPS beat(12)42.89%
EPS beat(16)11
Avg EPS beat(16)151.46%
Revenue beat(2)2
Avg Revenue beat(2)10.32%
Min Revenue beat(2)8.51%
Max Revenue beat(2)12.13%
Revenue beat(4)3
Avg Revenue beat(4)7.62%
Min Revenue beat(4)-1.19%
Max Revenue beat(4)12.13%
Revenue beat(8)4
Avg Revenue beat(8)3.11%
Revenue beat(12)7
Avg Revenue beat(12)3.8%
Revenue beat(16)10
Avg Revenue beat(16)3.09%
PT rev (1m)4.13%
PT rev (3m)5.47%
EPS NQ rev (1m)-1.14%
EPS NQ rev (3m)-31.92%
EPS NY rev (1m)0.68%
EPS NY rev (3m)-27.66%
Revenue NQ rev (1m)0.25%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)2.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.74 | ||
| Fwd PE | 23.14 | ||
| P/S | 3.43 | ||
| P/FCF | 10.62 | ||
| P/OCF | 9.64 | ||
| P/B | 3.01 | ||
| P/tB | 3.16 | ||
| EV/EBITDA | 9.33 |
EPS(TTM)2.48
EY7.85%
EPS(NY)1.37
Fwd EY4.32%
FCF(TTM)2.97
FCFY9.41%
OCF(TTM)3.28
OCFY10.37%
SpS9.22
BVpS10.5
TBVpS9.99
PEG (NY)N/A
PEG (5Y)0.39
Graham Number24.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.54% | ||
| ROE | 19.55% | ||
| ROCE | 19.33% | ||
| ROIC | 16.21% | ||
| ROICexc | 40.41% | ||
| ROICexgc | 45.55% | ||
| OM | 23.57% | ||
| PM (TTM) | 22.27% | ||
| GM | 85.93% | ||
| FCFM | 32.27% |
ROA(3y)8.82%
ROA(5y)3.68%
ROE(3y)13.16%
ROE(5y)4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.43%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 167.24% | ||
| Cap/Sales | 3.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 139.24% | ||
| Profit Quality | 144.88% | ||
| Current Ratio | 3.67 | ||
| Quick Ratio | 3.27 | ||
| Altman-Z | 6.61 |
F-Score6
WACC7.74%
ROIC/WACC2.09
Cap/Depr(3y)76.88%
Cap/Depr(5y)63.55%
Cap/Sales(3y)2.83%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.71%
EPS 3Y54.92%
EPS 5Y32.5%
EPS Q2Q%-31.94%
EPS Next Y-48.02%
EPS Next 2Y-31.39%
EPS Next 3Y-19.38%
EPS Next 5Y-4.73%
Revenue 1Y (TTM)1.08%
Revenue growth 3Y9.89%
Revenue growth 5Y5.87%
Sales Q2Q%4.24%
Revenue Next Year-2.6%
Revenue Next 2Y10.16%
Revenue Next 3Y6.82%
Revenue Next 5Y8.56%
EBIT growth 1Y-17.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-10.49%
EBIT Next 3Y-3.56%
EBIT Next 5Y16.39%
FCF growth 1Y93.26%
FCF growth 3Y76.56%
FCF growth 5YN/A
OCF growth 1Y83.26%
OCF growth 3Y62.84%
OCF growth 5Y43.53%
ALKERMES PLC / ALKS FAQ
What is the fundamental rating for ALKS stock?
ChartMill assigns a fundamental rating of 6 / 10 to ALKS.
What is the valuation status for ALKS stock?
ChartMill assigns a valuation rating of 6 / 10 to ALKERMES PLC (ALKS). This can be considered as Fairly Valued.
Can you provide the profitability details for ALKERMES PLC?
ALKERMES PLC (ALKS) has a profitability rating of 7 / 10.
What is the valuation of ALKERMES PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ALKERMES PLC (ALKS) is 12.74 and the Price/Book (PB) ratio is 3.01.
What is the expected EPS growth for ALKERMES PLC (ALKS) stock?
The Earnings per Share (EPS) of ALKERMES PLC (ALKS) is expected to decline by -48.02% in the next year.